MedTrace Logo

Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control Trial

NCT07763145 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2026-08-13

No results posted yet for this study

Summary

To determine the efficacy of citicoline in improving cerebral blood flow parameters and neurological status among neonates with hypoxic-ischemic encephalopathy using Doppler resistive index and Sarnat-Sarnat score after 72 hours of therapy.

Conditions

  • Hypoxic Ischaemic Encephalopathy (HIE)

Interventions

DRUG

Citicoline

This group will receive drug and standard care

OTHER

Standard medical treatment

This group will receive only standard care

Sponsors & Collaborators

  • Hayatabad Medical Complex

    collaborator OTHER_GOV

  • Khyber Girls Medical College

    lead OTHER

Principal Investigators

  • Romisa Rehman · Hyatabad Medical Complex

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Hours
Max Age
24 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07763145 on ClinicalTrials.gov